NEUROPATHOLOGIC VERIFICATION OF CREUTZFELDT-JAKOB DISEASE IN THE EXHUMED AMERICAN RECIPIENT OF HUMAN PITUITARY GROWTH-HORMONE - EPIDEMIOLOGIC AND PATHOGENETIC IMPLICATIONS

被引：41
|
作者：
TINTNER, R
BROWN, P
HEDLEYWHYTE, ET
RAPPAPORT, EB
PICCARDO, CP
GAJDUSEK, DC
机构：
[1] NIH, BLDG 36, ROOM 5B05, BETHESDA, MD 20205 USA
[2] UNIV TEXAS, HLTH SCI CTR, DEPT NEUROL, DALLAS, TX 75235 USA
[3] NINCDS, CNS STUDIES LAB, BETHESDA, MD 20205 USA
[4] MASSACHUSETTS GEN HOSP, NEUROPATHOL LAB, BOSTON, MA 02114 USA
[5] US FDA, DIV METAB & ENDOCRINE DRUG PROD, ROCKVILLE, MD 20857 USA
来源：
NEUROLOGY | 1986年 / 36卷 / 07期
关键词：
D O I：
10.1212/WNL.36.7.932
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：932 / 936
页数：5
相关论文
共 50 条
  • [41] Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France
    d'Aignaux, JH
    Costagliola, D
    Maccario, J
    de Villemeur, TB
    Brandel, JP
    Deslys, JP
    Hauw, JJ
    Chaussain, JL
    Agid, Y
    Dormont, D
    Alpérovitch, A
    NEUROLOGY, 1999, 53 (06) : 1197 - 1201
  • [42] Early cognitive decline in Creutzfeldt-Jakob disease occurring in recipients of pituitary-derived human growth hormone
    Cordery, RJ
    Hall, M
    Cipolotti, L
    Davidson, L
    Adlard, P
    Rossor, MN
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 72 (01): : 133 - 133
  • [43] Iatrogenic Creutzfeldt-Jakob disease in human growth hormone recipients in the United Kingdom
    Head, Mark W.
    Ritchie, Diane L.
    Yull, Helen M.
    Peden, Alexander H.
    Ironside, James W.
    PRION, 2016, 10 : S92 - S92
  • [44] THE PRISMATIC CASE OF CREUTZFELDT-JAKOB-DISEASE ASSOCIATED WITH PITUITARY GROWTH-HORMONE TREATMENT
    HINTZ, RL
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (08): : 2298 - 2301
  • [45] Susceptibility to Creutzfeldt-Jakob disease after human growth hormone treatment in France
    Peckeu, Laurene
    Brandel, Jean-Philippe
    Welaratne, Arlette
    Costagliola, Dominique
    Haik, Stephane
    NEUROLOGY, 2018, 91 (08) : E724 - E731
  • [46] Neurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone therapy in childhood
    Holmes, SJ
    Ironside, JW
    Shalet, SM
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 60 (03): : 333 - 335
  • [47] CREUTZFELDT-JAKOB DISEASE IN A RECIPIENT OF HUMAN PITUITARY-DERIVED GONADOTROPIN - A 2ND CASE
    COCHIUS, JI
    HYMAN, N
    ESIRI, MM
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1992, 55 (11): : 1094 - 1095
  • [48] Iatrogenic Creutzfeldt-Jakob disease following human growth hormone therapy - Case report
    Caboclo, LOSF
    Huang, N
    Lepski, GA
    Livramento, JA
    Buchpiguel, CA
    Porto, CS
    Nitrini, R
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2002, 60 (2B) : 458 - 461
  • [49] Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal Imaging
    Lewis, AM
    Yu, M
    DeArmond, SJ
    Dillon, WP
    Miller, BL
    Geschwind, MD
    ARCHIVES OF NEUROLOGY, 2006, 63 (02) : 288 - 290
  • [50] Creutzfeldt-Jakob disease 38 years after diagnostic use of human growth hormone
    Croes, EA
    Roks, G
    Jansen, GH
    Nijssen, PCG
    van Duijn, CM
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 72 (06): : 792 - 793
12345